We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
Figure 1

Figure 1. From: CMVIG decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.

Proportion of subjects receiving CMVIG by year of transplantation

K Ranganathan, et al. J Heart Lung Transplant. ;28(10):1050-1056.
2.
Figure 2

Figure 2. From: CMVIG decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.

Outcome including any CMV episodes, death or retransplantation, or no events before one year post-transplant categorized by the receipt of CMVIG and type of CMV episode. Reported as percentages of the total in each group A: CMV infection (excluding those with CMV disease without prior infection) (CMVIG n=49; no CMVIG n=220) B: CMV disease (CMVIG n=62, no CMVIG n=267)

K Ranganathan, et al. J Heart Lung Transplant. ;28(10):1050-1056.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk